medigraphic.com
Instituto Nacional de Salud Pública

2011, Número 4

<< Anterior

salud publica mex 2011; 53 (4)


Persisten las preguntas
Factores ambientales en las enfermedades autoinmunes

Idioma: Español
Referencias bibliográficas: 49
Paginas: 354-366
Archivo PDF: 495.34 Kb.


FRAGMENTO

Tras el nacimiento de su primera hija, comenzaron a aparecer moretones en el cuerpo de Stanley Finger. Despertado súbitamente la mayoría de las noches por el llanto de su bebé, Finger, semidormido, tropezaba al dirigirse hacia la habitación de aquél, golpeándose contra las paredes y los muebles en la oscuridad. “Mi esposa y yo bromeábamos al respecto”, dice Finger, ingeniero químico de Bluffton, Carolina del Sur. Sin embargo, durante un chequeo rutinario, Finger se enteró de que la causa de la facilidad con la que le salían moretones era que el número de sus plaquetas estaba disminuyendo drásticamente. El cuerpo depende de estos fragmentos celulares para la coagulación, y la cuenta de plaquetas de Finger había bajado a casi un tercio de su valor normal. Después de descartar el cáncer y otras enfermedades, el doctor de Finger llegó finalmente a un diagnóstico: púrpura trombocitopénica inmune (PTI).


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Segal JB, Powe NR. Prevalence of immune thrombocytopenia: analyses of administrative data. J Thrombo Haemost 2006;4(11):2377-2383; doi:10.1111/j.1538-7836.2006.02147.x

  2. Jacobson DL, et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997;84(3):223-243; doi:10.1006/clin.1997.4412

  3. The Autoimmune Diseases Coordinating Committee. Progress in autoimmune disease research. Informe al Congreso. Publicación del NIH Nº 05-5140. Bethesda, MD:The Autoimmune Diseases Coordinating Committee, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 2005 [consultado abril 27, 2011]. Disponible en: http://tinyurl.com/3wev5xh

  4. AARDA. The cost burden of autoimmune disease: The latest front in the war on healthcare spending. Eastpointe, MI: American Autoimmune Related Diseases Association, Inc., 2011 [consultado abril 27, 2011]. Disponible en: http://tinyurl.com/4yucztc

  5. AARDA. Questions & answers. How many americans have an autoimmune disease? [website]. Eastpointe, MI: American Autoimmune Related Diseases Association, Inc. [consultado abril 27, 2011]. Disponible en: http://tinyurl.com/44exjhg

  6. Podar T, et al. Increasing incidence of childhood-onset type I diabetes in 3 Baltic countries and Finland 1983-1998. Diabetologia 2001;44(suppl 3):B17-B20; PMID:11724410

  7. Grimaldi LME, et al. High prevalence and fast rising incidence of multiple sclerosis in Caltanissetta, Sicily, Southern Italy. Neuroepidemiology 2007;28(1):28-32; doi:10.1159/000097853

  8. Rubio-Tapia A, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009;137(1):88-93; doi:10.1053/j.gastro.2009.03.059

  9. Pollard KM, et al. Toxicology of autoimmune diseases. Chem Res Toxicol 2010;23(3):455-466; doi:10.1021/tx9003787

  10. Nagata C, et al. Systemic lupus erythematosus: a case–control epidemiologic study in Japan. Int J Dermatol 1995;34(5):333-337; PMID:7607794

  11. Hardy CJ, et al. Smoking history, alcohol consumption, and systemic lupus erythematosus: a case–control study. Ann Rheum Dis 1998;57:451-455; doi:10.1136/ard.57.8.451

  12. Bengtsson AA, et al. Risk factors for developing systemic lupus erythematosus: a case–control study in southern Sweden. Rheumatology 2002;41(5):563-571; doi:10.1093/rheumatology/41.5.563

  13. Weetman AP. Determinants of autoimmune thyroid disease. Nature Immunol 2001;2(9):769-770; doi:10.1038/ni0901-769

  14. Vestergaard P, et al. Smoking as a risk factor for Graves’ disease, toxic nodular goiter, and autoimmune hypothyroidism. Thyroid 2002;12(1):69-75; doi:10.1089/105072502753451995

  15. Reidenberg MM, et al. Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus. Arthritis Rheum 1993;36(7):971-973; doi:10.1002/art.1780360714

  16. Harjutsalo V, et al. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008;371(9626):1777-1782; doi:10.1016/S0140-6736(08)60765-5

  17. Patterson CC, et al. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet 2009;373(9680):2027-2033; doi:10.1016/S0140-6736(09)60568-7

  18. SEARCH for Diabetes in Youth Study [website]. Atlanta, GA: US Centers for Disease Control and Prevention; Bethesda, MD:National Institute of Diabetes and Digestive and Kidney Diseases, 2010 [consultado abril 28, 2011]. Disponible en: http://tinyurl.com/3fvtkfp

  19. Lamb MM, et al. Height growth velocity, islet autoimmunity, and type 1 diabetes development: the Diabetes Autoimmunity Study in the Young. Diabetologia 2009;52(10):2064-2071; doi:10.1007/s00125-009-1428-2

  20. Knip M, et al. Infant feeding and the risk of type 1 diabetes. Am J Clin Nutr 2010;91(5):1506S-1513S; doi:10.3945/ajcn.2010.28701C

  21. Ziegler A-G, et al. Early infant feeding and risk of developing type 1 diabetes–associated autoantibodies. JAMA 2003;290(13):1721-1728; doi:10.1001/jama.290.13.1721

  22. Virtanen SM, et al. Age at introduction of new foods and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes. Diabetologia 2006;49:1512-1521; doi:10.1007/s00125-006-0236-1

  23. Norris JM, et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 2003;290(13):1713-1720; doi:10.1001/jama.290.13.1713

  24. Couper JJ, et al. Lack of association between duration of breast-feeding or introduction of cow’s milk and development of islet autoimmunity. Diabetes 1999;48(11):2145-2149; doi:10.2337/diabetes.48.11.2145

  25. Yeung WC, et al. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011;342:d35; doi:10.1136/bmj.d35 [en línea el 3 de febrero de 2011].

  26. Longnecker MP, Daniels JL. Environ Health Perspect 2001;109(suppl 6):871-876; PMID:11744505

  27. Gourley M, Miller FW. Mechanisms of disease: environmental factors in the pathogenesis of rheumatic disease. Nat Clin Practice Rheumatol 2007;3(3):172-180; doi:10.1038/ncprheum0435

  28. Calvert GM, et al. Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 2003;60(2):122-129; doi:10.1136/oem.60.2.122

  29. Stolt P, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case–control study, using incident cases. Ann Rheum Dis 2003;62(9):835-841; doi:10.1136/ard.62.9.835

  30. Noonan CW, et al. Nested case–control study of autoimmune disease in an asbestosexposed population. Environ Health Perspect 2006;114(8):1243-1247; doi:10.1289/ehp.9203

  31. Costenbader KH, Karlson EW. Epstein–Barr virus and rheumatoid arthritis: is there a link? Arthritis Res Ther 2006;8(1):204-210; doi:10.1186/ar1893

  32. Gilbert KM, et al. Environmental contaminant trichloroethylene promotes autoimmune disease and inhibits T-cell apoptosis in MRL+/+ mice. J Immunotoxicol 2006;3(4):263-267; PMID:18958707

  33. Surveillance Epidemiology and End Results (SEER) Program [website]. Bethesda, MD:National Cancer Institute, National Institutes of Health [consultado abril 28, 2011]. Disponible en: http://tinyurl.com/5s6k5gq

  36. WNA. Radioactive waste management [página web]. Londres, RU: Asociación Nuclear Mundial [actualizado abril 2011-consultado abril 29, 2011]. Disponible en: http://tinyurl.com/448n8k7

  37. EPA. Strontium [página web]. Washington, DC: Agencia de Protección al Ambiente de EUA [actualizado marzo 25, 2011-consultado abril 29, 2011]. Disponible en: http:// tinyurl.com/ye5y6g4

  38. Krejci MR, et al. Selective sequestration of strontium in desmid green algae by biogenic co-precipitation with barite. Chem Sus Chem 2011;4(4):470-473; doi:10.1002/cssc.201000448

  39. Singh S, et al. Phytoremediation of 137cesium and 90strontium from solutions and low-level nuclear waste by Vetiveria zizanoides. Ecotoxicol Environ Saf 2008;69(2):306-311; doi:10.1016/j. ecoenv.2006.12.004

  40. DOE. Tank waste & waste processing [página web]. Washington, DC: Oficina de Manejo Ambiental, Departamento de Energía de EUA [consultado abril 29, 2011]. Disponible en: http://tinyurl.com/68xqs33

  41. Suzuki T. Daily update from Japan, 13 de abril, 6 pm, Tokio [columna]. Bull At Sci 2011 (edición en línea) [consultado abril 29, 2011]. Disponible en: http://tinyurl.com/66f2z9k

  44. Ghosh R, et al. Indoor coal use and early childhood growth. Arch Pediatr Adolesc Med 2011;165(6):492-497; doi:10.1001/archpediatrics.2010.294

  45. Karr CJ. Adding fuel to the fire. Increasing evidence for developmental toxicity of indoor solid fuel combustion. Arch Pediatr Adolesc Med 2011;165(6):565-566; doi:10.1001/archpediatrics.2011.6

  46. WHO. Fuel for Life: Household Energy and Health. Geneva, Switzerland: World Health Organization, 2006 [consultado abril 5, 2011]. Disponible en: http://tinyurl.com/6xemgpf

  47. Kyu HH, et al. Maternal smoking, biofuel smoke exposure and child height-for-age in seven developing countries. Int J Epidemiol 2009;38(5):1342-1350; doi:10.1093/ije/dyp253

  48. Mishra V, Retherford RD. Does biofuel smoke contribute to anaemia and stunting in early childhood? Int J Epidemiol 2007;36(1):117-129; doi:10.1093/ije/dyl234

  49. Baker RJ, et al. Coal home heating and environmental tobacco smoke in relation to lower respiratory illness in Czech children, from birth to 3 years of age. Environ Health Perspect 2006;114(7):1126-1132; doi:10.1289/ehp.8501




2020     |     www.medigraphic.com